首页> 外文期刊>Surgical innovation >Implantable Agents for Fecal Incontinence: An Age-Matched Retrospective Cohort Analysis of GateKeeper versus SphinKeeper
【24h】

Implantable Agents for Fecal Incontinence: An Age-Matched Retrospective Cohort Analysis of GateKeeper versus SphinKeeper

机译:用于粪便失禁的可植入剂:一个年龄匹配的追溯队列队列的守门员与偷窥者

获取原文
获取原文并翻译 | 示例
           

摘要

Background. We aim to evaluate morphofunctional changes of the sphincter complex after GateKeeper (GK) and SphinKeeper (SK) procedures and correlate these with symptom improvement.Methods. Ten consecutive females undergoing SK implant were age-matched with a cohort of 10 females who previously underwent the GK procedure. Patients in the SK and GK groups underwent implantation of 10 and 6 prostheses, respectively. Muscle tension (Tm), expressed in millinewtons per centimetre squared, mN (cm(2))(-1), was calculated using the equationTm=P(r(i))(tm)(-1), wherePis the average maximum squeeze pressure andr(i)andtmthe inner radius and thickness of the external anal sphincter, respectively. The pre- and postimplant changes inTmand Cleveland Clinic Fecal Incontinence Score (CCFIS) were tested by linear and Poisson regression models, respectively.Results. The CCFIS significantly improved in both groups at 12-month postimplantation. Although not reaching statistical significance, symptom improvement after SK was 33% above that observed after GK (P= .088). Compared to the baseline, a significant increase inTmwas observed in both groups at 12 months (GK, 508.1 [478.8-568.0] vs 864.4 [827.0-885.8] mN (cm(2))(-1); SK, 528.0 [472.7-564.0] vs 858.6 [828.0-919.6] mN (cm(2))(-1),P= .005). Compared to the GK group,Tmwas significantly higher in patients after SK implant (158.3 mN (cm(2))(-1)[95% confidence interval, 109.6-207.0];P< .001), after controlling for baseline values, at 12-month postimplantation.Conclusions. GK and SK are safe and effective treatments for FI with good short-term clinical outcomes. Comparative analysis showed superiority of SK over GK in terms of gain inTm, with borderline significantly better improvement in symptoms. Larger studies are needed to confirm these findings.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号